Roivant Sciences (ROIV) Shares Outstanding (2020 - 2026)

Roivant Sciences has reported Shares Outstanding for 7 years, with the latest figure at $720.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 3.51% year-over-year to $720.4 million; the trailing twelve-month figure through Mar 2026 stood at $720.4 million (up 3.51% YoY), and the FY2026 full-year result was $720.4 million, up 3.51% from the prior year.
• Shares Outstanding for Q1 2026 stood at $720.4 million, up from $709.7 million in the prior quarter.
• The five-year high for Shares Outstanding was $806.7 million in Q1 2024, with the low at $682.2 million in Q2 2025.
• Historically, Shares Outstanding has averaged $732.8 million across 5 years, with a median of $720.4 million in 2026.
• Annual changes were most pronounced in 2023 — Shares Outstanding advanced 13.69% — and 2025, when it retreated 13.73%.
• Roivant Sciences' Shares Outstanding stood at $726.8 million in 2022, then advanced by 10.74% to $804.9 million in 2023, then slipped by 10.59% to $719.6 million in 2024, then declined by 1.38% to $709.7 million in 2025, then advanced by 1.5% to $720.4 million in 2026.
• The last three Shares Outstanding figures came in at $720.4 million (Q1 2026), $709.7 million (Q4 2025), and $689.7 million (Q3 2025), per Business Quant data.